Event Type 2: Virtual

Join us for our first DDF Solution Showcase of the year as TransCelerate and CDISC convene sponsor companies, clinical solution providers, and key industry stakeholders. Missed a session? Watch past webinars here. 

During this webinar, our panelists will:

• Share information on innovative products and solutions in the protocol digitalization space aligned with DDF elements, including CDISC’s USDM standard 
• Present on the following topics and engage in a live Q&A:

  •  DDF in action: USDM-enabled study definitions in the Nurocor clinical platform
  • How Oracle protocol intelligence and build automation solutions accelerate clinical trial setup using USDM 

Panelists:

• Nurocor staff members:

  • Bob Brindle, VP Product Management
  • Barrie Nelson, President

• Oracle staff members:

  • Mircea Baciu, Senior Principal Application Consultant
  • Dan Conn, Consulting Technical Manager
  • Sarah Jamal, Strategic Client Advisor

Virtual control groups (VCGs) are gaining attention as a way to reduce reliance on traditional concurrent controls in preclinical toxicology. Anchored in experience from the European Innovative Health Initiative (IHI) project VICT3R, this webinar brings together consortia, industry, and regulatory perspectives to support engagement in this emerging area. 

During this webinar, our panelists will:

• Provide an introduction to VCGs and the current landscape
• Share early lessons learned from the IHI VICT3R project
• Discuss scientific and regulatory considerations for future adoption

Panelists:

• William Houser, Scientific Associate Director, Nonclinical Safety, Bristol-Myers Squibb  
• Karolina Kopanska, Postdoctoral Toxicologist, Johns Hopkins Center for Alternatives to Animal Testing (CAAT)
• Lars Mecklenburg, Executive Director, Data & Science, Labcorp Early Development 
• Lilliam Rosario, Program Director, TransCelerate
• Thomas Steger-Hartmann, Senior Project Lead, Innovative Health Initiative; VP, Bayer AG